Kornam

Terazosin, the active ingredient in Kornam, is a Alpha-1 adrenergic blocker presented as an oral formulation for oral use. It is employed to lower blood pressure in hypertension and to relax smooth muscle in the prostate and bladder neck for treatment of benign prostatic hyperplasia.

GNH USA supplies Kornam as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terazosin acts on the alpha-1 adrenergic receptor pathway to manage vascular and prostatic conditions. - Hypertension: lowers systemic blood pressure by causing vasodilation of peripheral arteries. - Benign prostatic hyperplasia (BPH): improves urinary flow by relaxing prostate and bladder neck smooth muscle. - Prostatic enlargement symptoms: reduces urinary frequency, urgency and nocturia associated with BPH.

Terazosin may cause a range of adverse reactions.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Nasal congestion - Peripheral edema - Nausea or abdominal discomfort

Serious or Rare Side Effects: - Severe hypotension or syncope - Priapism (prolonged erection) - Anaphylactic or severe allergic reaction - Liver injury (rare) - Cardiac arrhythmia (very rare)

Terazosin requires careful monitoring and patient education. - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Orthostatic precautions: advise patients to rise slowly to reduce dizziness. - Hepatic impairment: use with caution and consider dose adjustment in patients with liver disease. - Concomitant antihypertensives: avoid combining with other potent blood‑pressure‑lowering agents without supervision. - Pregnancy and breastfeeding: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Terazosin can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase terazosin plasma concentrations. - Other alpha‑blockers or strong antihypertensives: additive risk of severe hypotension.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance orthostatic hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): increase risk of low blood pressure. - Alcohol: can augment dizziness and hypotensive effects.